Enhanced recovery after pancreatic surgery: A prospective randomized controlled clinical trial

Author(s):  
Muhammer Ergenc ◽  
Sakir Karpuz ◽  
Merve Ergenc ◽  
Cumhur Yegen
2020 ◽  
Author(s):  
Jiali Chen ◽  
Xinyu Zhang ◽  
Ning Ning ◽  
Peifang Li ◽  
Yueer Zhang

Abstract Background Few studies reported the impact of nutrition management based on Enhanced Recovery after Surgery (ERAS) protocols in spinal surgery. The aim of this study was to examine the association of multidisciplinary nutrition management in percutaneous endoscopic interlaminar discectomy (PEID) with patients’ subjective feelings and postoperative recovery.Methods A randomized controlled clinical trial was conducted from August to November in 2017. A total of 101 patients undergoing PEID were randomized into two groups: a control group (50 patients experiencing traditional nutrition management) and an intervention group (51 patients experiencing multidisciplinary nutrition management). Fasting time, subjective feelings, satisfaction and postoperative recovery were evaluated in all patients.Results In all, 96 patients completed the study: 48 in each group. Our findings revealed that patients in intervention group had weaker preoperative hunger (p=0.036), preoperative thirst (p<0.001) and postoperative thirst (p=0.006), higher satisfaction about nutrition management (p=0.001), shorter pre and post-operative fasting liquids and solids time, and shorter first passage of flatus (p=0.005) than those of patients in control group.Conclusion Multidisciplinary nutrition management can promote patients’ subjective feelings and postoperative gastric recovery.Trial registration: Current Controlled Trials ChiCTR-IOQ-17011742, June/22/2017.


2017 ◽  
Vol 16 (1) ◽  
Author(s):  
Jesús Alberto Luengo - Fereira

Objective: To compare two fluorinated varnishes for the control of white spot lesions.Material and Methods: A randomized controlled clinical trial was conducted. A total of 103 active whitespot lesions on permanent upper anterior teeth from 24 patients, aged 7 to 9 years were randomly assigned totwo groups, G1: Duraphat® (n=52) and G2: DuraShield® (n=51). Weekly applications were perform for fourconsecutive weeks. Fifth week the dimension, regression and activity of the lesions were evaluated. Student’sT test, Wilcoxon Ranks and Chi square were used at 5% significance. Results: At the end of the study, the lesion reduction was observed in 69.7%, finding significant differences(p<0.05) in the mean of the initial and final dimensions in general (2.74 mm to 1.91 mm) and in each group, G1(2.84 mm to 2.03 mm), G2 (2.64 mm to 1.78 mm). In the activity of the lesions, it was found in the G1, 12 active and6 inactive lesions; while in G2, there were 14 active and 29 inactive; these differences were significant (p<0.05). Conclusions: The two evaluated products showed similar clinical efficacy in the remineralization of activewhite spot lesions after 4 weeks of therapy.


Sign in / Sign up

Export Citation Format

Share Document